Pharma Journalist -

Sarepta Therapeutics has announced significant updates to the U.S. prescribing information for ELEVIDYS, the only approved gene therapy for Duchenne muscular dystrophy (DMD). The…
Read More...

The FDA’s approval of KOMZIFTI™ (ziftomenib) represents a significant milestone for patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) harboring NPM1 mutations—one…
Read More...

Eisai and Biogen announced that the UK Medicines and Healthcare products Regulatory Agency has approved a once-every-four-weeks IV maintenance dosing regimen for Leqembi (lecanemab), an…
Read More...

Mangoceuticals has launched MangoRx Direct and PeachesRx Direct, new programs offering customers direct access to FDA-approved GLP-1 medications Zepbound (tirzepatide) and Wegovy…
Read More...

MeiraGTx Holdings plc has announced a broad strategic collaboration with Eli Lilly and Company focused on advancing gene therapies for ophthalmic diseases, including a groundbreaking…
Read More...

Insilico Medicine, a clinical-stage company pioneering generative AI-driven drug discovery, has announced a new research collaboration with Eli Lilly and Company to jointly develop…
Read More...

SanegeneBio, a clinical-stage biotechnology company focused on RNAi therapeutics, has entered a global research and licensing collaboration with Eli Lilly and Company to develop…
Read More...

Harbour BioMed and Evinova have announced a strategic collaboration to integrate artificial intelligence (AI) and digital technologies into biologics research and development. The…
Read More...

Novartis has announced the opening of a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, California — a major step in the company’s $23 billion,…
Read More...

Lyell Immunopharma, Inc., a late-stage clinical biotech company developing next-generation chimeric antigen receptor (CAR) T-cell therapies, has strengthened its solid tumor portfolio…
Read More...